Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                14%
                                OVERLAP
BY WEIGHT
6
                                # OF OVERLAPPING
HOLDINGS
FBT
                            31
                                HOLDINGS
                            
                                    20%
                                
                                ALSO IN PSCH
                            PSCH
                            69
                                HOLDINGS
                            
                                    9%
                                
                                ALSO IN FBT
                            SECTOR DRIFT (FBT minus PSCH)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT  | 
                                Weight in PSCH  | 
                                Overlap | |
|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC | 3.1% | 5.2% | 3.1% | |
| ALKERMES PLC | 3.1% | 3.2% | 3.1% | |
| KRYSTAL BIOTECH, INC. | 3.4% | 2.9% | 2.9% | |
| VERACYTE INC | 3.3% | 1.8% | 1.8% | |
| ACADIA PHARMACEUTICALS INC | 3.6% | 1.7% | 1.7% | |
FBT Overweight Relative to PSCH
                | ILLUMINA INC | 4.2% | |
| NATERA INC | 3.7% | |
| REGENERON PHARMACEUTICALS | 3.6% | |
| INCYTE CORP | 3.5% | |
| METTLER-TOLEDO INTERNATIONAL | 3.5% | |
| EXACT SCIENCES CORP | 3.5% | |
| BRUKER CORP | 3.5% | |
| WATERS CORP | 3.3% | |
| BIOGEN IDEC INC | 3.3% | |
| NEUROCRINE BIOSCIENCES INC | 3.3% | 
FBT Underweight Relative to PSCH
                | TELEFLEX INC | -3.6% | |
| RADNET INC | -3.4% | |
| GLAUKOS CORP | -3.1% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -3.1% | |
| MERIT MEDICAL SYSTEMS INC | -3.1% | |
| TG THERAPEUTICS INC | -3.1% | |
| TRANSMEDICS GROUP, INC. | -2.5% | |
| PROTAGONIST THERAPEUTICS, INC. | -2.4% | |
| INTEGER HOLDINGS CORPORATION | -2.3% | |
| LIGAND PHARMACEUTICALS-CL B | -2.2% |